Private Wealth Management Group’s Soleno Therapeutics SLNO Stock Holding History

Private Wealth Management Group’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-54	Closed	-$1.81K	–	1506
2026 Q1	$1.81K	Buy	+54	New	+$2.12K	﹤0.01%	1111

Private Wealth Management Group's SLNO Position: Q2 2026 in Review

Private Wealth Management Group sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 54 shares — an estimated $1.81K sold.

Private Wealth Management Group first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $1.81K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Private Wealth Management Group reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Private Wealth Management Group sold 54 Soleno Therapeutics shares in Q2 2026, an estimated $1.81K.
Private Wealth Management Group first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Private Wealth Management Group's Soleno Therapeutics position peaked at $1.81K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.